Tender Offer - TriSalus Life Sciences, Inc.

Form Type: SC TO-I/A

Filing Date: 2025-07-15

Corporate Action: Tender-offer

Type: Update

Accession Number: 000164117225019710

Filing Summary: This document is an amendment to the Tender Offer Statement on Schedule TO initially filed by TriSalus Life Sciences, Inc. on June 23, 2025. The amendment pertains to an issuer tender offer to stockholders of the Series A Convertible Preferred Stock. The company is offering holders a number of shares of the company's common stock in exchange for each share of preferred stock tendered, based on an established 'Exchanged Value' calculated from the Liquidation Preference and Accrued Dividends due through August 10, 2027, divided by the Exchange Price set at $4.00. Additionally, the company is soliciting consents from Preferred Stock Holders to amend the governing certificate of the Preferred Stock to permit future conversions of outstanding Exchange Preferred stock into common stock. The document states that this amendment does not modify any previously reported information except as specifically provided and has updated the previous Prospectus/Offer to Exchange to replace the earlier filing attached as an exhibit. It showcases that the updates were made to ensure compliance and provide clearer communication to the stockholders about the terms and conditions of the offer.